3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Multiple Myeloma
235
Precursor Cell Lymphoblastic Leukemia-Lymphoma
69
Recurrence
36
Burkitt Lymphoma
34
Leukemia
32
Lymphoma
30
Neoplasms, Plasma Cell
22
Lymphoma, Non-Hodgkin
19
Immunoglobulin Light-chain Amyloidosis
18
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
17
Lymphoma, Mantle-Cell
16
Neoplasms
15
Nausea
15
Lymphoma, Large B-Cell, Diffuse
15
Vomiting
14
Hodgkin Disease
13
Breast Neoplasms
12
Waldenstrom Macroglobulinemia
11
Leukemia, Biphenotypic, Acute
11
Lymphoma, Follicular
10
Lymphoma, B-Cell, Marginal Zone
10
Amyloidosis
10
Lung Neoplasms
9
Smoldering Multiple Myeloma
8
Prostatic Neoplasms
8
Neoplasm Metastasis
8
Leukemia, Myeloid, Acute
8
Hematologic Neoplasms
7
Blast Crisis
7
Lymphoma, T-Cell, Cutaneous
6
Interventions
Tea
3
Polyethylene Glycols
3
Infliximab
3
MEDI2070
2
Lidocaine
2
Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18
2
sodium phosphate
1
prucalopride
1
polyethylene glycol 400
1
picosulfate sodium
1
golimumab
1
cabozantinib
1
Surgical Tape
1
Standard of Care
1
Spectrum Analysis, Raman
1
Specimen Handling
1
Pneumococcal Vaccines
1
Platinum Compounds
1
Passive Cutaneous Anaphylaxis
1
Papillomavirus Vaccines
1
Oxygen
1
Nivolumab
1
Neomycin
1
Narrow Band Imaging
1
Morphine
1
Metronidazole
1
Medical Marijuana
1
Laparoscopy
1
Ipilimumab
1
Indocyanine Green
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Inflammatory Bowel Diseases
×
Calcium Dobesilate
×
Clear all
NCT03723447
2021-02-17
TINGLE
Cedars-Sinai Medical Center
Phase 4
Completed
102 enrolled
9 charts